Emcure partners with Sunsure Energy for major solar power initiative

New Delhi: Emcure Pharmaceuticals has announced a significant step in its sustainability journey by signing a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, a major renewable power producer in India.

This agreement, which includes Emcure’s subsidiary Gennova Biopharmaceuticals aims to provide approximately 36 million units of clean, renewable energy annually to their Pune plants.

Under this partnership, Emcure and Gennova will meet around 67% of their power requirements for these plants with green energy, effectively offsetting 29,765.71 metric tons of CO2 emissions annually. This move underscores Emcure’s dedication to sustainable practices and reducing its environmental impact.

Emcure and Gennova have also signed a Shareholders Agreement to acquire a stake in Sunsure Solarpark Twelve Private Limited, enabling the purchase of solar power under a group captive scheme as per the Electricity Act, 2023.

With a presence in over 70 countries, Emcure Pharmaceuticals has long been recognized for its commitment to improving lives through innovative pharmaceutical solutions. This new agreement will see Sunsure Energy supplying power from its 150 MWp DC solar plant in Solapur, Maharashtra, further enhancing Emcure’s sustainability initiatives.

Commenting on the agreement, Sunil Mehta, Whole-time Director of Emcure Pharmaceuticals Ltd., stated, “At Emcure, we are dedicated not only to improving lives through innovation and research for our differentiated portfolio but also through efficient and environment-friendly manufacturing processes. Our partnership with Sunsure Energy is a testament to promoting innovative solutions in the pharmaceutical industry to reduce the industry’s carbon footprint by embracing the power of renewable energy.”

Shashank Sharma, Founder and CEO of Sunsure Energy, added, “We are thrilled to onboard Emcure Pharmaceuticals to our esteemed family of customers. This PPA demonstrates Sunsure’s dedication to facilitating the renewable energy transition for leading corporations in the pharmaceutical sector. By working together, we are not only powering Emcure’s facilities with clean energy but also driving broader environmental stewardship within the industry.”

Emcure Pharmaceuticals has expressed its commitment to environmental sustainability, incorporating green initiatives and eco-friendly practices throughout its operations. The company adheres to good manufacturing practices (cGMP) and international standards, using energy-efficient equipment and advanced waste management systems. Emcure also practices rainwater harvesting and solvent recycling. Its 13 manufacturing plants are equipped with Zero Liquid Discharge systems and Effluent Treatment Plants, ensuring 100% waste treatment.